Hae Jin Kim Selected Research

Albumins

5/2017	Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study.
1/2016	Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hae Jin Kim Research Topics

Disease

31	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2004
24	Insulin Resistance 01/2020 - 04/2004
11	Inflammation (Inflammations) 09/2021 - 01/2011
8	Obesity 01/2021 - 06/2008
7	Body Weight (Weight, Body) 01/2018 - 06/2006
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 04/2004
5	Non-alcoholic Fatty Liver Disease 01/2022 - 10/2004
5	Diabetes Complications 01/2022 - 05/2012
5	Hyperglycemia 01/2020 - 10/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2004
4	Neoplasms (Cancer) 01/2020 - 02/2018
4	Ganglion Cysts (Ganglion) 08/2017 - 09/2016
4	Atherosclerosis 01/2017 - 11/2010
4	Glucose Intolerance 01/2017 - 03/2009
3	Fibrosis (Cirrhosis) 01/2022 - 06/2020
3	Fatty Liver 09/2021 - 11/2016
3	Heart Failure 01/2020 - 09/2017
3	Dementia (Dementias) 01/2020 - 12/2018
3	Hypertension (High Blood Pressure) 05/2017 - 11/2014
3	Hypoxia (Hypoxemia) 01/2016 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 09/2021
2	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2016
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 12/2004
2	Pain (Aches) 02/2018 - 07/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2018 - 09/2016
2	Glaucoma 07/2017 - 01/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 04/2004
2	Abdominal Obesity 01/2017 - 01/2011
2	Hypertrophy 11/2016 - 05/2007
2	Albuminuria 01/2016 - 01/2015
1	Lymphedema (Milroy Disease) 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2022

Drug/Important Bio-Agent (IBA)

21	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 06/2006
8	Triglycerides (Triacylglycerol)IBA 01/2022 - 04/2004
8	PalmitatesIBA 01/2020 - 11/2010
7	Insulin (Novolin)FDA Link 01/2022 - 08/2006
7	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2021 - 01/2016
6	CytokinesIBA 01/2022 - 06/2008
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2008
5	Nicotinamide PhosphoribosyltransferaseIBA 09/2021 - 12/2011
5	AdiponectinIBA 01/2019 - 06/2008
5	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 05/2007
5	LipidsIBA 01/2018 - 10/2006
5	Rosiglitazone (Avandia)FDA Link 07/2008 - 06/2006
4	AdipokinesIBA 09/2021 - 06/2008
4	SodiumIBA 01/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2007
4	Retinaldehyde (Retinal)IBA 08/2017 - 09/2016
4	C-Reactive ProteinIBA 01/2017 - 04/2004
4	CholesterolIBA 06/2011 - 10/2006
3	FructoseIBA 01/2022 - 11/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2008
3	Pharmaceutical PreparationsIBA 04/2018 - 10/2011
3	Metformin (Glucophage)FDA LinkGeneric 02/2018 - 02/2011
3	CreatinineIBA 05/2017 - 12/2006
3	fibroblast growth factor 21IBA 07/2016 - 05/2012
3	oxidized low density lipoproteinIBA 09/2013 - 10/2006
3	HDL CholesterolIBA 10/2006 - 04/2004
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 11/2016
2	InterleukinsIBA 01/2022 - 06/2008
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2008
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 11/2016
2	EnzymesIBA 01/2022 - 01/2011
2	ChemokinesIBA 01/2022 - 06/2020
2	Choline (Choline Chloride)IBA 01/2022 - 09/2021
2	LC15-0444IBA 01/2022 - 11/2018
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 11/2021 - 08/2019
2	SymportersIBA 01/2021 - 01/2018
2	dapagliflozinIBA 01/2021 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2019 - 10/2011
2	ORALIT (ORS)IBA 01/2019 - 04/2004
2	Messenger RNA (mRNA)IBA 01/2019 - 05/2007
2	IronIBA 01/2019 - 05/2015
2	CalciumIBA 01/2019 - 01/2017
2	AlbuminsIBA 05/2017 - 01/2016
2	Blood Glucose (Blood Sugar)IBA 11/2016 - 06/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 09/2013 - 04/2011
2	LDL CholesterolIBA 09/2013 - 10/2006
2	Testosterone (Sustanon)FDA Link 12/2011 - 04/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2011 - 10/2006
2	LeptinIBA 07/2008 - 06/2008
2	Perilipin-1IBA 05/2007 - 06/2006
1	Adenosine Triphosphate (ATP)IBA 10/2022
1	alogliptinIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	Pioglitazone (Actos)FDA Link 01/2022
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	empagliflozinIBA 01/2022

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2013
5	Glycemic Control 08/2019 - 09/2013
2	Radiofrequency Ablation 02/2018 - 09/2016
2	Aftercare (After-Treatment) 05/2017 - 01/2016